drugset / Trial / NCT05781906
Human Mass Balance of [14C]HMPL-523 in Healthy Adult Male Chinese Subjects
NaSequentialOpen-labelHealth-services research
Summary
To evaluate the absorption, metabolism and excretion of HMPL-523 in healthy male Chinese subjects following multiple oral doses of HMPL-523 tablets followed by a single oral dose of \[14C\]HMPL-523 suspension
Timeline
- Start
- 2023-02-08
- Primary completion
- 2023-06-01
- Completion
- 2023-12-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sovleplenib | Small molecule | 300 mg | Oral |